Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06528171
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
Covid-19 Long Immunité IMagerie CLIIM
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Specific Markers of Covid-long Syndrome Identifying the Mechanisms Involved With a View to Defining Diagnostic Criteria
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CLIIM
Brief Summary:
Covid-long pathology affects a large number of patients and represents a major medical economic and societal challenge To date we have no objective criterion for a definitive diagnosis nor any predictive tool for monitoring the evolution of Covid-long Based on recruitment from the infectious diseases department of Nice University Hospital the investigators team wants to conduct an innovative pathophysiological study to better define the disease and identify specific biomarkers that could subsequently be used as a diagnostic tool for Covid-long 120 participants will be initially included for the model learning phase 60 controls in the CL- cohort and 60 patients in the CL cohort Then 80 patients 40 CL and 40 Cl- will be enrolled for the model validation phase
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None